(877) 320-5131 Menu

(877) 320-5131


8900 Wilshire Blvd, Suite 200
Beverly Hills, CA 90211

Patient Portal

International Patients

Book an Appointment

Contact Us Today

Breast Cancer Clinical Trials

Recruiting

1280-0022 Xenera-1: A multi-centre, double-blind, placebo-controlled,randomised phase II trial to compare efficacy of xentuzumab incombination with everolimus and exemestane versus everolimus andexemestane in post-menopausal women with HR+ / HER2-metastatic breast cancer and non-visceral disease

A phase II, multicenter, open-label, two-cohort, noncomparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole in patients with PIK3CA mutant, hormone receptor (HR) positive, HER2- negative advanced breast cancer (aBC), who have progressed on or after CDK 4/6 inhibitor treatment (BYLieve)

Carrick Therapeutics: CT7001_002: A Phase 1/2 Study of CT7001 in Combination with Fulvestrant in Patients with Metastatic or Locally Advanced Hormone-Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer:

G1 Therapeutics G1T48-01: A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability,Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 inWomen with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

Genentech: WO41554: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF GDC-0077 PLUS PALBOCICLIB AND FULVESTRANT VERSUS PLACEBO PLUS PALBOCICLIB AND FULVESTRANT IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PIK3CA-MUTANT HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER:

Upcoming

DZ2019ER001 Study for Breast Cancer: A Phase I/II, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of DZD3969 as Monotherapy or in combination with Palbociclib in Postmenopausal Female Patients with Estrogen Receptor Positive (ER+) and HER2 Negative (HER2-) Breast Cancer:

Astellas: An Open-Label, Multicenter, Multi-Cohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202):

Not Recruiting

A companion sample collection study to support the discovery of breast cancer aberrations with treatment of CDK4/6 therapy/LEE011/Ribociclib

COMPLEEMENT-1: An open-label, multicenter, Phase IIIb study to assess the safety and efficacy of ribociclib (LEE011) in combination with letrozole for the treatment of men and pre/postmenopausal women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior hormonal therapy for advanced disease

Madeline: Prospective Observational Study of Mobile App-Based Patient-Reported Outcomes in Advanced Breast Cancer

monarchE: Protocol I3Y-MC-JPCF A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer

POLARIS: Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study

SOLAR-1: A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment

SOLAR-1: A phase III randomized double-blind, placebo controlled study of alpelisib in combination with fulvestrant for men and postmenopausal women with hormone receptor positive, HER2-negative advanced breast cancer which progressed on or after aromatase inhibitor treatment

Schedule a Consultation Today!

Your health is important, and we welcome the opportunity to help you heal.

To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or use our interactive Online Appointment Request Form.

Beverly Hills Cancer Center

About Us

Cancer Care Services

Imaging Services

Research & Clinical Trials

Information Center

Contact Us

Features

Contact US Today

Loading...

Rate Us!

Please take a moment to rate your experience with our team.

Yelp Google Facebook
Rate Us

Update Regarding COVID-19 View Update We Are Open (Call or Email)

COVID-19 and Cancer Patients

What is COVID-19?

COVID-19 is a new type of virus that can cause mild to severe infections in the lungs. Like other viruses, it can lead to serious infections for people with weakened immune systems. COVID-19 may cause more severe infections than other viruses. We do not have a vaccine to help control its spread, but experts are working to make a vaccine.

How does COVID-19 spread?

The virus can spread easily, just like the common cold or flu. It spreads when an infected person coughs or sneezes droplets that can get into the eyes, nose, or mouth of people nearby. Droplets also land on surfaces that people touch before touching their own eyes, nose, or mouth.

How can I protect myself?

These are some of the best ways to protect yourself and others from the virus:

  • Wash your hands often with soap and water for at least 20 seconds.
  • Use hand sanitizer with 60% or more alcohol until you can wash your hands with soap and water.
  • Avoid touching your eyes, nose, and mouth without washing your hands first.
  • Clean and disinfect surfaces often. Regular household wipes and sprays will kill the virus. Be sure to clean places that people touch a lot, such as door handles, phones, keyboards, and light switches.
  • Avoid handshakes, hugging, and standing or sitting close to people who are coughing or sneezing.
  • Be as healthy as you can. Get plenty of sleep, eat healthy, exercise, and manage your stress. If you are sick, follow these steps:
  • Stay home.
  • Cover your nose and mouth when you cough or sneeze. If you use a tissue, put it in the garbage right away. If you do not have a tissue, cough or sneeze into your elbow crease.
  • Call before going to your medical appointments. Let them know about recent travel or if you have had contact with a person with COVID-19.

What should I do if I have cancer?

Some people with cancer might have a higher risk of getting COVID-19 or having a serious infection from it. Do your best to follow the steps listed above to protect yourself. Ask your doctor or nurse if they have special recommendations based on your health or type of treatment.

Call your doctor right away if any of these happen to you:

  • You have a fever higher than 100.3 degrees F.
  • You feel short of breath.
  • You develop a cough, runny nose, or congestion.

Should I wear a mask?

It is recommended to wear a mask in pubic at all times. Please wear a mask at all times while at Beverly Hills Cancer Center as well. This can help prevent the spread of the virus, and protect both you and those around you.

What if I care for or live with a cancer patient?

If you are caring for or living with someone with cancer, do your best to keep them from getting the virus. Follow the steps to protect yourself listed on this sheet.

If you become sick yourself, call your doctor to see what more you should do to protect your loved one.

What about people visiting?

If you are sick or have been exposed to COVID-19, we ask that you not come to Beverly Hills Cancer Center. We ask that you find someone who isn’t sick to join your loved one at their appointments.

To protect all patients, we may limit the number of people who can visit someone staying in the hospital. Please check with your care team.

How will Beverly Hills Cancer Center protect me from getting COVID-19

Our Facility is taking steps to keep patients separate from those who may be at risk. At every appointment, your care team will ask questions about overall health and recent travel. Patients and anyone entering the center will have their temperature checked upon arrival, and will be asked to wear a mask. Visitors are limited if they are not actual patients, including family members, and translation services are also being conducted by phone or video instead of in person. Staff members are wearing increased protective equipment. We may ask some patients to wait in a separate room or to reschedule until they are feeling better if they have any symptoms. Everyone must respect social distancing protocols wherever possible including in the waiting room, infusion area and clinic.

We are also taking extra steps to clean and disinfect surfaces throughout our Facility between each patient, and deeper cleaning each evening.

Will you still care for me if I get sick?

Yes. Your care is our top priority. Although we may change some ways we care for you, we will never put your care or health at risk.

Is there care available for International Patients?

For international patients, we are here for you each step of the way. We have resources for private travel arrangements, including private jet, private car transfers from airport, and relationships with local housing and hotel options with the top safety and cleanliness precautions.

Beverly Hills Cancer Center 8900 Wilshire Blvd, Suite 200 Beverly Hills CA 90211 310-432-8900